{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:48:59Z","timestamp":1790376539148,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Tuberculosis continues to be a health problem of both developed and developing countries, and its incidence has currently increased due to HIV induced immune suppression. HIV-co-infection decreases the total number of CD4+ T cells since the virus preferentially replicates with in activated CD4+ T cells and macrophages, resulting in the disruption of granuloma to contain M. tuberculosis. In this study, we investigated the change in T lymphocyte subpopulations before and after anti-tubercular treatment and the effect of intestinal parasites on the cell populations of tuberculosis patients before the initiation of anti TB treatment.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Method<\/jats:title>\n<jats:p>A prospective cohort study was conducted in the outpatient TB Clinic, University of Gondar hospital between January 2014 and August 2015. Blood samples were collected from 80 newly diagnosed TB patients with and without HIV co-infection. The mean CD4+ and CD8+ T lymphocyte counts of the patients were assessed before and after the course of anti-TB treatment. The mean values of T lymphocytes of TB, TB\/HIV co-infected patients and of the control groups were compared. Data was analyzed by SPSS version 16 and the graph pad prism software.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 80 tuberculosis patients 40 of whom were co-infected with HIV participated in our study. The mean CD4\u2009+\u2009T lymphocytes counts of the TB\/HIV cohort were 354.45\u2009\u00b1\u2009138cell\/\u03bcl, and the mean CD8+ cell counts were 926.82\u2009\u00b1\u2009384cell\/\u03bcl. There were significant changes in the mean CD4+ and CD8+ T cell counts after the course of anti-TB treatment in both groups of patients(<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). However, no statistically significant differences were observed in the mean CD4\u2009+\u2009and CD8+ T cell counts of helminthes infected and non-infected patients (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We found significantly lower CD4+ T cell counts among TB infected HIV negative patients compared with controls who showed that TB was the cause of non\u2013HIV-associated declination of circulating CD4 counts, and the reduction was reversible with anti-tubercular treatment in both HIV-negative and ART na\u00efve TB-HIV co-infected patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-4845-y","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T10:02:47Z","timestamp":1581069767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6842-9629","authenticated-orcid":false,"given":"Tadelo","family":"Wondmagegn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasu","family":"Damtie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaza","family":"Genetu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belete","family":"Biadgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulualem","family":"Lemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Negash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"4845_CR1","first-page":"30","volume":"56","author":"VK Chadha","year":"2009","unstructured":"Chadha VK. Progress towards millennium development goals for TB control in seven Asian countries. Indian J Tuberculosis. 2009;56:30\u201343.","journal-title":"Indian J Tuberculosis"},{"key":"4845_CR2","first-page":"165","volume":"100","author":"RG Loudon","year":"1969","unstructured":"Loudon RG, Bumgarner LR, Lacy J, Coffman GK. Aerial transmission of mycobacteria. Am Rev Respir Dis. 1969;100:165\u201371.","journal-title":"Am Rev Respir Dis"},{"key":"4845_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.00042-10","volume":"24","author":"CK Kwan","year":"2011","unstructured":"Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24:351\u201376.","journal-title":"Clin Microbiol Rev"},{"key":"4845_CR4","unstructured":"Organization WH. Global tuberculosis report 2017: World Health Organization; 2017. https:\/\/www.who.int\/tb\/publications\/global_report\/gtbr2017_main_text.pdf."},{"issue":"8","key":"4845_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1365-3156.2005.01456.x","volume":"10","author":"D Maher","year":"2005","unstructured":"Maher D, Harries A, Getahun H. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Tropical Med Int Health. 2005 Aug;10(8):734\u201342.","journal-title":"Tropical Med Int Health"},{"key":"4845_CR6","unstructured":"UNAIDS \u2018East and Southern Africa: Data 2016\u2019 (Accessed 01 Nov 2018)."},{"key":"4845_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1086\/651500","volume":"50","author":"M Harrington","year":"2010","unstructured":"Harrington M. From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. Clin Infect Dis. 2010;50:260\u20136.","journal-title":"Clin Infect Dis"},{"key":"4845_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/MI\/2006\/89070","volume":"2006","author":"Figen Deveci","year":"2006","unstructured":"Deveci F, Akbulut HH, Celik I, Muz MH, \u0130lhan F. Lymphocyte Subpopulations in Pulmonary Tuberculosis Patients. Mediators of Inflammation, 2006;1\u20136. https:\/\/doi.org\/10.1155\/mi\/2006\/89070.","journal-title":"Mediators of Inflammation"},{"issue":"4","key":"4845_CR9","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1128\/IAI.01126-10","volume":"79","author":"CR Diedrich","year":"2011","unstructured":"Diedrich CR, Flynn JL. HIV-1\/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun. 2011;79(4):1407\u201317.","journal-title":"Infect Immun"},{"issue":"6","key":"4845_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1286-4579(02)01582-4","volume":"4","author":"SD Lawn","year":"2002","unstructured":"Lawn SD, Butera ST, Shinnick TM. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to mycobacterium tuberculosis. Microbes Infect. 2002;4(6):635\u201346.","journal-title":"Microbes Infect"},{"issue":"6","key":"4845_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/2047-783X-16-6-285","volume":"16","author":"A Al-Aska","year":"2011","unstructured":"Al-Aska A, Al-Anazi A, Al-Subaei S, Al-Hedaithy M, Barry M, Somily A, et al. CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia. Eur J Med Res. 2011;16(6):285.","journal-title":"Eur J Med Res"},{"issue":"4","key":"4845_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0167-5699(95)80119-7","volume":"16","author":"Z Bentwich","year":"1995","unstructured":"Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today. 1995;16(4):187\u201391.","journal-title":"Immunol Today"},{"issue":"1","key":"4845_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1172\/JCI115300","volume":"88","author":"GF Del Prete","year":"1991","unstructured":"Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, et al. Purified protein derivative of mycobacterium tuberculosis and excretory-secretory antigen (s) of Toxocaracanis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 1991;88(1):346\u201350.","journal-title":"J Clin Invest"},{"key":"4845_CR14","doi-asserted-by":"crossref","unstructured":"Federal Ministry of Health Ethiopia. Tuberculosis, Leprosy and TB\/HIV Prevention and Control Programme: Clinical guideline 2012; 33\u201340. Available from: https:\/\/www.who.int\/hiv\/pub\/guidelines\/ethiopia_tb.pdf; Retrived 9 October 2017.","DOI":"10.22328\/2077-9828-2017-9-4-33-40"},{"key":"4845_CR15","unstructured":"Formal Ether Sedimentation technique for the concentration of stool parasites: online medical microbiology guide 2013; Available from: https:\/\/microbeonline.com\/formal-ether-sedimentation-techniques\/\u201d; Retrieved 3 August 2017."},{"issue":"1","key":"4845_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/cyto.b.20018","volume":"61","author":"S Uppal","year":"2004","unstructured":"Uppal S, Tewari S, Verma S, Dhot P. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study. Cytometry B Clin Cytom. 2004;61(1):20\u20136.","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"4845_CR17","first-page":"189","volume":"49","author":"S Swaminathan","year":"2002","unstructured":"Swaminathan S, Sangeetha M, Arunkumar N, Menon P, Thomas B, Shibi K, et al. Pulmonary tuberculosis in HIV individuals: preliminary report on clinical features and response to treatment. Indian J Tuberc. 2002;49(4):189\u201393.","journal-title":"Indian J Tuberc"},{"issue":"1","key":"4845_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/1471-2334-13-468","volume":"13","author":"R Vashishtha","year":"2013","unstructured":"Vashishtha R, Mohan K, Singh B, Devarapu SK, Sreenivas V, Ranjan S, et al. Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study. BMC Infect Dis. 2013;13(1):468.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4845_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/clinids\/24.5.988","volume":"24","author":"BE Jones","year":"1997","unstructured":"Jones BE, Oo MM, Taikwel EK, Qian D, Kumar A, Maslow ER, et al. CD4 cell counts in human immunodeficiency virus\u2014negative patients with tuberculosis. Clin Infect Dis. 1997;24(5):988\u201391.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4845_CR20","first-page":"1031","volume":"2","author":"S Kavya","year":"2017","unstructured":"Kavya S, Anuradha K, Venkatesha D. CD4 count evaluation in HIV-TB co infection before and after anti-tubercular treatment. Int J Res Med Sci. 2017;2(3):1031\u20134.","journal-title":"Int J Res Med Sci"},{"issue":"5","key":"4845_CR21","first-page":"548","volume":"129","author":"L Hanna","year":"2009","unstructured":"Hanna L, Nayak K, Subramanyam S, Venkatesan P, Narayanan P, Swaminathan S. Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis. Indian J Med Res. 2009;129(5):548.","journal-title":"Indian J Med Res"},{"issue":"2","key":"4845_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009138","volume":"5","author":"CS Mahan","year":"2010","unstructured":"Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, et al. Tuberculosis treatment in HIV infected Ugandans with CD4 counts> 350 cells\/mm3 reduces immune activation with no effect on HIV load or CD4 count. PLoS One. 2010;5(2):e9138.","journal-title":"PLoS One"},{"issue":"4","key":"4845_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1128\/CMR.05040-11","volume":"25","author":"HJ McSorley","year":"2012","unstructured":"McSorley HJ, Maizels RM. Helminth infections and host immune regulation. Clin Microbiol Rev. 2012;25(4):585\u2013608.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"4845_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1365-2249.2003.02106.x","volume":"132","author":"A Kassu","year":"2003","unstructured":"Kassu A, Tsegaye A, Wolday D, Petros B, Aklilu M, Sanders E, et al. Role of incidental and\/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin Exp Immunol. 2003;132(1):113\u20139.","journal-title":"Clin Exp Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-4845-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T05:56:11Z","timestamp":1612763771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-4845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4845"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-4845-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"assertion":[{"value":"29 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data was collected after ethical clearance was obtained from the School of Biomedical and Laboratory Sciences, College of Medicine and Health Science, the University of Gondar. After discussion of the purpose and aims of the study, permission was also obtained from the Head, the University of Gondar hospital prior to data collection. Informed written consent was also obtained from the participants. To ensure the confidentiality of participants\u2019 information, anonymous typing was used; names, identification numbers, and any other personal identifiers were not extracted during data collection. Moreover, the data was kept in a confidential manner.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}